Holen Sie sich die Stockscreener-App
0.21
0.96%
0.002
Handel nachbörslich:
.20
-0.010
-4.76%
Schlusskurs vom Vortag:
$0.208
Offen:
$0.202
24-Stunden-Volumen:
231.20K
Relative Volume:
0.31
Marktkapitalisierung:
$4.04M
Einnahmen:
$5.54M
Nettoeinkommen (Verlust:
$-4.74M
KGV:
-0.625
EPS:
-0.336
Netto-Cashflow:
$-750.60K
1W Leistung:
-4.50%
1M Leistung:
+9.20%
6M Leistung:
-20.75%
1J Leistung:
-56.43%
1-Tages-Spanne:
$0.2001
$0.2139
1-Wochen-Bereich:
$0.194
$0.2388
52-Wochen-Spanne:
$0.13
$0.599
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Firmenname
China Pharma Holdings Inc.
Sektor
Telefon
86 898 6681 1730
Adresse
No. 17, Jinpan Road, Second Floor, Haikou
Vergleichen Sie CPHI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.21 | 4.04M | 5.54M | -4.74M | -750.60K | -0.336 |
|
ZTS
Zoetis Inc
|
165.89 | 74.84B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
12.92 | 40.96B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.92 | 24.83B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
143.26 | 14.50B | 2.24B | 385.90M | 440.10M | 3.73 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2010-01-08 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Aktie (CPHI) Neueste Nachrichten
China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World
China Pharma (NYSE:CPHI) Now Covered by StockNews.com - Defense World
Dry Eye Products Market Opportunities and Strategies to - GlobeNewswire
Layoff Tracker: Regeneron Acquisition of Oxular Wipes Out Oxular Workforce - BioSpace
Li Ka-Shing-Backed Hutchmed Sells Stake in Unit for $608 Million - MSN
Barclays PLC Has $759,000 Holdings in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World
StockNews.com Begins Coverage on China Pharma (NYSE:CPHI) - Defense World
China Pharma Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 - Marketscreener.com
China Pharma Holdings, Inc. Rescinds Securities Purchase Agreement - Defense World
PetVivo Holdings, Inc. to Make Investor Presentations - Defense World
Keen Vision Acquisition Extends Business Combination PeriodKeen Vision Acquisition Corporation (NASDAQ: KVAC) has recently filed a Form 8-K with the Securities and Exchange Commission, announcing the extension of its business combination period. T - Defense World
AmpliTech Group Enters Securities Purchase Agreement with Institutional InvestorsWASHINGTON, D.C., December 24, 2024 – AmpliTech Group, Inc. (NASDAQ: AMPG) disclosed today in an 8-K filing with the Securities and Exchange Commission that it has - Defense World
Blackboxstocks Inc. Dismisses Turner, Stone & Company as Independent Registered Public Accounting Firm; Engages Victor Mokuolo CPA PLLC as ReplacementOn December 20, 2024, Blackboxstocks Inc. (NASDAQ: BLBX) made significant changes in its a - Defense World
The Glimpse Group Announces Closing of $7.29 Million OfferingWASHINGTON, D.C., December 23, 2024 – The Glimpse Group, Inc. (NASDAQ:VRAR) disclosed the finalization of a registered direct offering on December 23, 2024. The undertaking involved a - Defense World
Creative Medical Technology Holdings, Inc. Reports Amendment to Articles of Incorporation and Voting Results Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) filed a Form 8-K with the Securities and Exchange Commission on December 19, 20 - Defense World
Analysts Set Celsius Holdings, Inc. (NASDAQ:CELH) Price Target at $50.28 - Defense World
China Pharma Holdings, Inc. Successfully Conducts Annual Stockholders’ Meeting - Defense World
GlycoMimetics Receives Extension Notice from Nasdaq Regarding Minimum Bid Price ComplianceOn December 19, 2024, GlycoMimetics, Inc. (NASDAQ: GLYC) disclosed in an 8-K filing with the Securities and Exchange Commission that it had received an e - Defense World
**Rhinebeck Bancorp Completes Balance Sheet Repositioning, Projects Earnings Growth** - Defense World
Wrap Technologies Reports Approval of Incentive Plan Amendment and Director Elections at Annual Meeting - Defense World
Financial Review: Autozi Internet Technology (Global) (NASDAQ:AZI) vs. Driven Brands (NASDAQ:DRVN) - Defense World
Aker BP ASA (OTCMKTS:AKRBF) Trading Down 1.7% – Here’s What Happened - Defense World
Edesa Biotech, Inc. (NASDAQ:EDSA) Short Interest Update - Defense World
Financial Survey: Flagstar Financial (FLG) and Its Peers - Defense World
White Gold Corp. (OTCMKTS:WHGOF) Short Interest Down 99.3% in December - Defense World
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com - Defense World
HighTower Advisors LLC Grows Holdings in American Century STOXX U.S. Quality Growth ETF (NYSEARCA:QGRO) - Defense World
Items Tagged with 'Jeil Pharma Holdings Inc.' - BioWorld Online
Hengrui Pharma accelerates bid for global brand status - Bamboo Works
China Pharma settles convertible note obligations By Investing.com - Investing.com Australia
China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville - Citizentribune
China Pharma settles convertible note obligations - Investing.com
China Pharma (CPHI) Strengthens Balance Sheet with Early $5.25M Convertible Note Redemption - StockTitan
Merck enters obesity drug race in pact with Chinese pharma Hansoh - Seeking Alpha
Act Fast and You Can Still Enroll In An ACA Healthcare Plan for 2025 - 69News WFMZ-TV
With Correct Measurements, Wine Really May Protect Heart - 69News WFMZ-TV
Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist - Yahoo Finance
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights - Yahoo Finance
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com - Defense World
U.S. Energy Enters Purchase and Sale Agreement with 84 Resources Holdings: Date of Agreement December 12, 2024 - Defense World
Werner Enterprises, Inc. (NASDAQ:WERN) Given Average Recommendation of “Reduce” by Brokerages - Defense World
NewAmsterdam Pharma (NASDAQ:NAMS) Enters into Underwriting Agreement for Public OfferingNEW YORK–(BUSINESS WIRE)– December 13, 2024– NewAmsterdam Pharma Company N.V. (NAMS) announced today the completion of an underwritten pub - Defense World
Reviva Pharmaceuticals Holdings, Inc. Holds Annual Meeting and Approves Increase in Authorized Shares - Defense World
Lloyds Banking Group plc (LON:LLOY) Given Average Recommendation of “Hold” by Brokerages - Defense World
Worksport Ltd. Shares Latest Corporate Updates, Crypto Investment Approaches as Market Position Strengthens - Defense World
Kimco Realty Corporation (KIM) Announces Final Results of Tender Offer and Consent Solicitation - Defense World
3D Systems Enters Agreement to Sell Geomagic Software Portfolio - Defense World
At The Market Sales Agreement: MediaCo Holding Inc. Enters Agreement with BTIG, LLC and Moelis & Company LLC - Defense World
Hub Group, Inc. (NASDAQ:HUBG) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Finanzdaten der China Pharma Holdings Inc.-Aktie (CPHI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.94%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):